Anaplastic Oligodendroglioma (AO) Completed Phase 2 Trials for Nintedanib (DB09079)

Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant

IndicationStatusPhase
DBCOND0052374 (Anaplastic Oligodendroglioma (AO))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01380782BIBF 1120 for Recurrent High-Grade GliomasTreatment